Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
Conditions
Glioblastoma Multiforme · Glioma, Malignant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
Study leads
Fusheng Liu, MD,PhD
Study Director
Beijing Tiantan Hospital